James Medcalf

James Medcalf

Auto-generated profile, based on publicly available information

James Medcalf

Department of Cardiovascular Sciences, University of Leicester, and John Walls Renal Unit, Leicester General Hospital, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom (N.J.B., J.M.).

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2021 in Clinical Kidney Journal
Verified
Journal Article
Open access
PDF file
HSHaresh Selvaskandan
Haresh Selvaskandan
ANAilish Nimmo
Ailish Nimmo
MSManuela Savino
Manuela Savino
SASarah Afuwape
Sarah Afuwape
SBSarah Brand
Sarah Brand
HBHannah Beckwith
Hannah Beckwith
Background: The coronavirus disease 2019 (COVID-19) pandemic is placing a significant strain on healthcare. We conducted a national survey of the UK nephrology workforce to understand its impacts on their working lives. Methods: An online questionnaire incorporating the Maslach Burnout Inventory score was distributed between 31 March and 1 May 2021, with a focus on COVID-19 and long COVID incidence, vaccine uptake, burnout and working patterns. Data were analysed qualitatively and quantitatively; multivariable logistic regression was used to identify associations. Results: A total of 423 responses were received. Of them, 29% had contracted COVID-19, which was more common among doctors and nurses {odds ratio [OR] 2.18 [95% confidence interval (CI) 1.13–4.22]} and those <55 years of age [OR 2.60 (95% CI 1.38–4.90)]. Of those who contracted COVID-19, 36% had symptoms of long COVID, which was more common among ethnicities other than White British [OR 2.57 (95% CI 1.09–6.05)]. A total of 57% had evidence of burnout, which was more common among younger respondents [OR 1.92 (95% CI 1.10–3.35)] and those with long COVID [OR 10.31 (95% CI 1.32–80.70)], and 59% with reconfigured job plans continued to work more hours. More of those working full-time wished to retire early. A total of 59% experienced remote working, with a majority preference for continuing this in the future. In terms of vaccination, 95% had received one dose of a COVID-19 vaccine and 86% had received two doses by May 2021. Conclusions: Burnout and long COVID is prevalent with impacts on working lives. Some groups are more at risk. Vaccination uptake is high and remote and flexible working were well received. Institutional interventions are needed to prevent workforce attrition.

10 July 2018 in Nephron
Verified
Journal Article
Open access
PDF file
SMStephanie J. MacNeill
Stephanie J. MacNeill
DFDaniel Ford
Daniel Ford
KEKatharine Evans
Katharine Evans
JMJames F. Medcalf
James F. Medcalf
There were 63,162 adult patients receiving renal replacement therapy (RRT) in the UK on 31 December 2016, an absolute increase of 3.1% from 2015.. The actual number of patients increased by 0.9% for haemodialysis (HD), 5.1% for those with a functioning transplant and less than 0.1% for peritoneal dialysis (PD).. The UK adult prevalence of RRT was 962 per million population (pmp). The reported prevalence in 2000 was 523 pmp.

1 January 2026 in Annals of Internal Medicine
Verified
Journal Article
Closed access
HHHiddo Heerspink
Hiddo Heerspink
MGMorgan E. Grams
Morgan E. Grams
YSYingying Sang
Yingying Sang
SBShoshana H. Ballew
Shoshana H. Ballew
JCJosef Coresh
Josef Coresh
WZWaleed Zafar
Waleed Zafar
Urinary albumin-creatinine ratio (UACR) and urinary protein-creatinine ratio (UPCR) are both used in clinical practice to diagnose and monitor chronic kidney disease (CKD). Which measure exhibits stronger associations with clinical outcomes and whether this varies by patient characteristics are unknown. To assess and compare the performance of UACR and UPCR across CKD-related clinical outcomes. Individual patient-level meta-analysis. 38 research and clinical cohorts. 148 994 participants with same-day measurements of UACR and UPCR. We quantified the associations of UACR and UPCR with subsequent clinical outcomes, including kidney failure and cardiovascular events, using Cox proportional hazards regression. Analyses were done in each cohort, followed by random-effects meta-analysis. Subgroups included those based on severity of proteinuria, type 2 diabetes, estimated glomerular filtration rate (eGFR) less than 60 mL/min/1.73 m2, and glomerular disease. There were 148 994 participants and 9773 kidney failure events during a median of 3.8 years of follow-up. Higher UACR and UPCR both had a log-linear association with increased risk for kidney failure. The association with kidney failure was somewhat stronger for UACR (adjusted hazard ratio [HR] per SD increment, 2.55 [95% CI, 2.36 to 2.74]) than UPCR (HR, 2.40 [CI, 2.28 to 2.53]; P for comparison<0.001). Results were consistent to slightly stronger in subgroups with UACR greater than 30 mg/g, UPCR greater than 500 mg/g, eGFR less than 60 mL/min/1.73 m2, diabetes, and glomerular disease. Associations between UACR and UPCR were generally similar for cardiovascular outcomes but favored UACR in subgroups with moderately to severely elevated UACR. Assessment of UACR and UPCR in spot urine samples. Overall, UACR was more strongly associated with kidney failure than UPCR (particularly in subgroups with higher UACR), supporting the use of UACR rather than UPCR to diagnose and risk-stratify patients. National Kidney Foundation and National Institute of Diabetes and Digestive and Kidney Diseases.

4 December 2024 in Nephrology Dialysis Transplantation
Verified
Journal Article
Closed access
EWEsther Wong
Esther Wong
RSRetha Steenkamp
Retha Steenkamp
DNDorothea Nitsch
Dorothea Nitsch
JMJames F Medcalf
James F Medcalf

7 February 2025 in BJGP Open
Verified
Journal Article
Open access
PDF file
CLChristoph Heinrich Lindemann
Christoph Heinrich Lindemann
JMJames Medcalf
James Medcalf
JHJames Hollinshead
James Hollinshead
DNDorothea Nitsch
Dorothea Nitsch
Background: With ageing of the population, both prevalence of chronic kidney disease (CKD) and incidence of kidney replacement therapy (KRT) are rising. Existing research suggests that Read-coding for CKD in those affected is associated with better implementation of recommended care and fewer hospitalisations for heart failure. Aim: To investigate whether coding for CKD is associated with regional KRT incidence in England. Design & setting: This is an ecological study using the clinical commissioning groups (CCGs) in England as geographical units. Method: KRT incidence rates were calculated using UK Renal Registry (UKRR) data from January 2019–December 2021. Data on the percentage of uncoded CKD patients (PUCP), who had laboratory evidence of CKD but lacked a diagnostic code, were obtained from the CVDPREVENT Audit, a national audit that extracts routinely held GP data. Data on confounders and acute kidney injury (AKI) mortality as a marker for population frailty were obtained from CVDPREVENT and the UKRR, respectively. Poisson models assessed the association between PUCP and KRT incidence. Results: After adjusting, the PUCP was non-linearly associated with KRT incidence, with the CCGs in the lowest PUCP quintile having a lower KRT incidence than the others. There was evidence that this association was more pronounced in CCGs with high AKI mortality compared with CCGs with low AKI mortality. Conclusion: At the geographical level in England, the data suggest that the prevalence of not having formally diagnosed CKD is non-linearly associated with a higher KRT incidence rate, especially in areas with a high AKI mortality.